• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

抗血管内皮生长因子注射后眼内炎的季节性和环境变化:六年回顾。

Seasonal and Environmental Variations in Endophthalmitis after Intravitreal Anti-vascular Endothelial Growth Factor Injection: A Six-year Review.

机构信息

The Retina Service of Wills Eye Hospital, Mid Atlantic Retina, Thomas Jefferson University, Philadelphia, PA, USA.

Lewis Katz School of Medicine, Temple University, Philadelphia, PA, USA.

出版信息

Curr Eye Res. 2022 Sep;47(9):1288-1293. doi: 10.1080/02713683.2022.2093383. Epub 2022 Jul 4.

DOI:10.1080/02713683.2022.2093383
PMID:35759609
Abstract

PURPOSE

To evaluate seasonal and environmental variations on the incidence and outcomes of postinjection endophthalmitis.

METHODS

A single-center, retrospective cohort study was conducted including all patients diagnosed with post-injection endophthalmitis between 2013-2018. Associations between climate variables and endophthalmitis incidence were evaluated.

RESULTS

Of 423,297 injections administered, seasonal distribution in spring, summer, autumn, and winter was 26%, 27%, 25%, and 22%, respectively. Of 171 cases of endophthalmitis identified, seasonal distribution over the spring, summer, autumn, and fall was 25%, 23%, 26%, and 26%, respectively. Endophthalmitis incidence was not correlated with monthly precipitation ( = 0.45), monthly snowfall ( = 0.49), or monthly temperature ( = 0.65). Worse visual outcomes at initial endophthalmitis presentation were correlated with increased precipitation level ( = 0.025) but were not correlated with snowfall level ( = 0.228) or mean monthly temperature ( = 0.132). Although there were no seasonal variations of visual acuity at endophthalmitis presentation ( = 0.894), odds of final visual acuity returning to within two lines of pre-endophthalmitis visual acuity were worse among patients with endophthalmitis diagnosed in the spring (OR, 0.041;  = 0.016).

CONCLUSION

In contrast to previous work on postcataract endophthalmitis, seasonal and weather factors were not associated with post-injection endophthalmitis risk or bacterial species isolated. Visual outcomes at initial endophthalmitis presentation were correlated with precipitation, and worse visual outcomes were seen in patients who developed endophthalmitis in the spring.

摘要

目的

评估注射后眼内炎发病和结局的季节性和环境变化。

方法

对 2013-2018 年间诊断为注射后眼内炎的所有患者进行了一项单中心、回顾性队列研究。评估了气候变量与眼内炎发病率之间的关系。

结果

在 423297 次注射中,春季、夏季、秋季和冬季的季节分布分别为 26%、27%、25%和 22%。在 171 例眼内炎病例中,春季、夏季、秋季和冬季的季节分布分别为 25%、23%、26%和 26%。眼内炎发病率与每月降水量( = 0.45)、每月降雪量( = 0.49)或月平均温度( = 0.65)无关。初始眼内炎表现时较差的视力结局与降水水平增加相关( = 0.025),但与降雪水平( = 0.228)或月平均温度( = 0.132)无关。尽管初始眼内炎表现时的视力没有季节性变化( = 0.894),但在春季诊断为眼内炎的患者中,最终视力恢复到眼内炎前视力的两线以内的可能性较低(OR,0.041; = 0.016)。

结论

与先前关于白内障术后眼内炎的研究结果不同,季节性和天气因素与注射后眼内炎的风险或分离出的细菌种类无关。初始眼内炎表现时的视力结果与降水有关,在春季发生眼内炎的患者中,视力结果较差。

相似文献

1
Seasonal and Environmental Variations in Endophthalmitis after Intravitreal Anti-vascular Endothelial Growth Factor Injection: A Six-year Review.抗血管内皮生长因子注射后眼内炎的季节性和环境变化:六年回顾。
Curr Eye Res. 2022 Sep;47(9):1288-1293. doi: 10.1080/02713683.2022.2093383. Epub 2022 Jul 4.
2
Incidence and visual outcomes of acute endophthalmitis post intravitreal injection of anti-vascular endothelial growth factors in a single referral center.单一转诊中心玻璃体内注射抗血管内皮生长因子后急性眼内炎的发病率及视力预后
Int Ophthalmol. 2023 Mar;43(3):867-876. doi: 10.1007/s10792-022-02489-x. Epub 2022 Sep 14.
3
LONG-TERM VISUAL OUTCOMES AND CLINICAL FEATURES AFTER ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR INJECTION-RELATED ENDOPHTHALMITIS.抗血管内皮生长因子注射相关性眼内炎的长期视力预后和临床特征。
Retina. 2019 Nov;39(11):2070-2076. doi: 10.1097/IAE.0000000000002300.
4
Postinjection Endophthalmitis Rates and Characteristics Following Intravitreal Bevacizumab, Ranibizumab, and Aflibercept.玻璃体内注射贝伐单抗、雷珠单抗和阿柏西普后的注射后眼内炎发生率及特征
Am J Ophthalmol. 2016 May;165:88-93. doi: 10.1016/j.ajo.2016.02.028. Epub 2016 Mar 2.
5
Postinjection endophthalmitis in the comparison of age-related macular degeneration treatments trials (CATT).年龄相关性黄斑变性治疗试验(CATT)中的注射后眼内炎
Ophthalmology. 2015 Apr;122(4):817-21. doi: 10.1016/j.ophtha.2014.10.027. Epub 2015 Jan 15.
6
Incidence of Endophthalmitis after Intravitreal Anti-vascular Endothelial Growth Factor: Experience in Saudi Arabia.玻璃体内注射抗血管内皮生长因子后眼内炎的发生率:沙特阿拉伯的经验
Middle East Afr J Ophthalmol. 2016 Jan-Mar;23(1):60-3. doi: 10.4103/0974-9233.171756.
7
Endophthalmitis following Intravitreal Anti-Vascular Endothelial Growth Factor Therapy: Changes in Incidence and Outcomes over a 9-Year Period.玻璃体内抗血管内皮生长因子治疗后眼内炎:9年期间发病率和结局的变化
Curr Eye Res. 2021 Sep;46(9):1370-1377. doi: 10.1080/02713683.2021.1874023. Epub 2021 Jan 31.
8
COMPARATIVE RISK OF ENDOPHTHALMITIS AFTER INTRAVITREAL INJECTION WITH BEVACIZUMAB, AFLIBERCEPT, AND RANIBIZUMAB.贝伐单抗、阿柏西普和雷珠单抗玻璃体内注射后眼内炎的比较风险。
Retina. 2019 Oct;39(10):2004-2011. doi: 10.1097/IAE.0000000000002351.
9
Endophthalmitis after Intravitreal Injection of Vascular Endothelial Growth Factor Inhibitors: Management and Visual Outcomes.眼内注射血管内皮生长因子抑制剂后的眼内炎:处理和视力结果。
Ophthalmology. 2018 Aug;125(8):1279-1286. doi: 10.1016/j.ophtha.2018.01.022. Epub 2018 Feb 21.
10
The Impact of Prefilled Syringes on Endophthalmitis Following Intravitreal Injection of Ranibizumab.预充式注射器对雷珠单抗玻璃体内注射后眼内炎的影响。
Am J Ophthalmol. 2019 Mar;199:200-208. doi: 10.1016/j.ajo.2018.11.023. Epub 2018 Dec 13.